Spectral Medical

About:

Spectral Medical focuses on the development and commercialization of a treatment for septic shock.

Top Investors: Birch Hill Equity Partners, Toray Industries, Paradigm Capital, Medwell Capital

Description:

Spectral Medical focuses on the development and commercialization of a treatment for septic shock using its endotoxin activity assay (EAA) diagnostic and the toraymyxin therapeutic.

Total Funding Amount:

$50.8M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Toronto, Ontario, Canada

Founded Date:

1991-01-01

Contact Email:

info(AT)spectraldx.com

Founders:

George Jackowski

Number of Employees:

1-10

Last Funding Date:

2024-07-22

IPO Status:

Public

Industries: